In order to determine any association between the Axin2 polymorphism and the risk of prostate cancer, the present study focused on rs2240308 (G/A) and compared the polymorphic region between 103 patients with prostate cancer and 100 control males. Here, AXIN2 is linked to prostate carcinoma.